Bioequivalence Study of Perampanel Tablets 10 mg

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 22, 2023

Primary Completion Date

November 26, 2023

Study Completion Date

February 6, 2024

Conditions

Epilepsy

Interventions

DRUG

Perampanel 10 MG

1 tablet of Perampanel Tablets 10mg

DRUG

Fycompa 10Mg Tablet

1 tablet of Perampanel Tablets 10mg

Trial Locations (1)

Raptim Research Pvt. Ltd.,, Navi Mumbai

All Listed Sponsors

lead

Humanis Saglık Anonim Sirketi

INDUSTRY

NCT06450236 - Bioequivalence Study of Perampanel Tablets 10 mg | Biotech Hunter | Biotech Hunter